Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escalating Dose Intravenous Methotrexate Without Leucovorin Rescue Versus Oral Methotrexate and Single Versus Double Delayed Intensification for Children With Standard Risk Acute Lymphoblastic Leukemia

NCT00005945 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00005945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escalating Dose Intravenous Methotrexate Without Leucovorin Rescue Versus Oral Methotrexate and Single Versus Double Delayed Intensification for Children With Standard Risk Acute Lymphoblastic Leukemia
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2000
Completion date
June 30, 2008
Enrollment
3,054 (actual)
Sites
130

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia